Novelix Pharmaceuticals

Operating within the pharma industry, Trimurthi Limited is engaged in the business of trading pharmaceuticals and related products, as well as trading shares and securities. The company’s new management desires to expand into organic and inorganic chemicals, pharmaceuticals, drugs, and intermediates to better reflect its core business objectives. A key objective is to undertake research for developing and marketing new indigenous technologies for various medicines and therapeutic uses. Its business activities include manufacturing, buying, selling, and acting as commission agents for a wide range of chemical and pharmaceutical products. The company is also involved in the business of herbal products, bio-chemicals, and bio-technology products, including research and development in these areas. During the 2023-24 financial year, the company generated revenue from operations of ₹422.38 Lakhs, marking a substantial growth over the previous year.;